In summary, the results demonstrated that a CRHR1 antagonist alleviates LPS-induced depression-like behaviour in male mice by inhibiting CRHR1/nectin3 signalling, which further increased the expression of calbindin. Here, NECTIN3 is linked to depressive disorder.